Evidence map›Paper›PMID 23976945›Full record

ArticlePloS one2013

Disruption of basal lamina components in neuromotor synapses of children with spastic quadriplegic cerebral palsy.

Karyn G Robinson, Janet L Mendonca, Jaimee L Militar, Mary C Theroux, Kirk W Dabney, Suken A Shah, Freeman Miller, Robert E Akins

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Does Time Tick Faster in Cerebral Palsy? Accelerated Aging as a Framework for Skeletal Muscle Dysfunction.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  4. Review
  5. Modeling cerebral palsy in animals.Developmental medicine and child neurology · 2026
    Review
  6. Article
  7. Article
  8. An Emerging Role for Epigenetics in Cerebral Palsy.Journal of personalized medicine · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Novel insights into cerebral palsy.Journal of muscle research and cell motility · 2020
    Article
  13. Article
  14. Article
  15. Morphofunctional characteristics of skeletal muscle in rats with cerebral palsy.International journal of experimental pathology · 2019
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Karyn G RobinsonNemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States of America.
Janet L Mendonca
Jaimee L Militar
Mary C Theroux
Kirk W Dabney
Suken A Shah
Freeman Miller
Robert E Akins
Alfred I. duPont Hospital for Children · US

Funding

VOLUMETRIC BREAST DENSITY ESTIMATION USING BREAST SURFACE RECONSTRUCTEDP20RR016472 · NCRR · UNIVERSITY OF DELAWARE · PI MENNELLA, PRINCY QUADROS · 2001 to 2011
$37.6M
Center for Pediatric ResearchP20GM103464 · NIGMS · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI SHAFFER, THOMAS H · 2012 to 2014
$5.6M
Development of neuromuscular junctions in children with cerebral palsyR03HD051738 · NICHD · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI AKINS, ROBERT E · 2007 to 2008
$126k
NCRR NIH HHS P20 RR016472NCRR NIH HHS RR016472NICHD NIH HHS HD051738NICHD NIH HHS R03 HD051738NIGMS NIH HHS GM103464NIGMS NIH HHS P20 GM103464
6 · The paper itself

Abstract

Cerebral palsy (CP) is a static encephalopathy occurring when a lesion to the developing brain results in disordered movement and posture. Patients present with sometimes overlapping spastic, athetoid/dyskinetic, and ataxic symptoms. Spastic CP, which is characterized by stiff muscles, weakness, and poor motor control, accounts for ∼80% of cases. The detailed mechanisms leading to disordered movement in spastic CP are not completely understood, but clinical experience and recent studies suggest involvement of peripheral motor synapses. For example, it is recognized that CP patients have altered sensitivities to drugs that target neuromuscular junctions (NMJs), and protein localization studies suggest that NMJ microanatomy is disrupted in CP. Since CP originates during maturation, we hypothesized that NMJ disruption in spastic CP is associated with retention of an immature neuromotor phenotype later in life. Scoliosis patients with spastic CP or idiopathic disease were enrolled in a prospective, partially-blinded study to evaluate NMJ organization and neuromotor maturation. The localization of synaptic acetylcholine esterase (AChE) relative to postsynaptic acetylcholine receptor (AChR), synaptic laminin β2, and presynaptic vesicle protein 2 (SV2) appeared mismatched in the CP samples; whereas, no significant disruption was found between AChR and SV2. These data suggest that pre- and postsynaptic NMJ components in CP children were appropriately distributed even though AChE and laminin β2 within the synaptic basal lamina appeared disrupted. Follow up electron microscopy indicated that NMJs from CP patients appeared generally mature and similar to controls with some differences present, including deeper postsynaptic folds and reduced presynaptic mitochondria. Analysis of maturational markers, including myosin, syntrophin, myogenin, and AChR subunit expression, and telomere lengths, all indicated similar levels of motor maturation in the two groups. Thus, NMJ disruption in CP was found to principally involve components of the synaptic basal lamina and subtle ultra-structural modifications but appeared unrelated to neuromotor maturational status.

Indexed as

AcetylcholinesteraseAdolescentBasement MembraneCase-Control StudiesCerebral PalsyChildFemaleGene ExpressionHumansLamininMaleMembrane GlycoproteinsMicroscopy, ElectronMuscle, SkeletalNerve Tissue ProteinsNeuromuscular JunctionAcetylcholinesteraseLamininlaminin beta2Membrane GlycoproteinsNerve Tissue ProteinsReceptors, CholinergicSV2A protein, humanSV2B protein, human

Identifiers

PMID23976945
PMCPMC3745387
OpenAlexW2048035463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.